Health Enterprise Partners
Description
Health Enterprise Partners (HEP) is a distinguished private equity firm based in New York, specializing exclusively in the healthcare sector. The firm targets companies within healthcare services and healthcare information technology, seeking to partner with businesses that demonstrate strong growth potential and innovative solutions. HEP's investment philosophy centers on providing capital and strategic support to accelerate the development of its portfolio companies, aiming to build market-leading enterprises within the complex healthcare ecosystem.
HEP primarily engages in growth equity investments, recapitalizations, and buyouts. The firm's typical equity check size ranges from $20 million to $70 million per transaction, although they possess the flexibility to participate in larger deals through co-investment structures. This strategic flexibility allows HEP to support a diverse range of companies, from established businesses seeking expansion capital to management teams looking for a strategic partner in a buyout scenario. Their approach emphasizes collaborative partnerships with management, leveraging their deep industry expertise and network to drive operational improvements and market expansion.
With a history of successful fundraises, including the closing of Health Enterprise Partners V at $650 million in 2022, HEP demonstrates significant capital capacity and a sustained commitment to the healthcare market. The firm's long-term vision is focused on creating enduring value by supporting companies that address critical needs and inefficiencies within healthcare. Their value-add extends beyond capital, encompassing strategic guidance, operational best practices, and access to a broad network of industry relationships, all designed to foster sustainable growth and enhance enterprise value for their portfolio companies.
Investor Profile
Health Enterprise Partners has backed more than 36 startups, with 0 new investments in the last 12 months alone. The firm has led 17 rounds, about 47% of its total and boasts 14 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B, Private Equity rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Health Care, Medical, Wellness.
- Typical check size: $20M – $70M.
Stage Focus
- Series A (33%)
- Series B (19%)
- Private Equity (19%)
- Series Unknown (14%)
- Series C (11%)
- Corporate Round (3%)
Country Focus
- United States (100%)
Industry Focus
- Health Care
- Medical
- Wellness
- Information Technology
- Software
- Hospital
- Analytics
- Therapeutics
- Health Diagnostics
- Medical Device
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
